Similar articles

• Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strains.

  Horaud F. Horaud F. Dev Biol Stand. 1993;78:149-54; discussion 154-5. Dev Biol Stand. 1993. PMID: 8388825 No abstract available.
• WHO recommendation on potential use of new poliomyelitis vaccines.

  Ghendon Y. Ghendon Y. Dev Biol Stand. 1993;78:133-7; discussion 138-9. Dev Biol Stand. 1993. PMID: 8388823
• Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.

  [No authors listed] [No authors listed] Bull World Health Organ. 1969;40(6):925-45. Bull World Health Organ. 1969. PMID: 4310724 Free PMC article. No abstract available.
• [Recent advance in research on the incidence of paralysis following immunization with live oral polio vaccine].

  Hu XM. Hu XM. Zhonghua Liu Xing Bing Xue Za Zhi. 1985 Apr;6(2):125-7. Zhonghua Liu Xing Bing Xue Za Zhi. 1985. PMID: 2990717 Review. Chinese. No abstract available.
• Safety aspects of oral poliovirus vaccine campaigns.

  Hovi T. Hovi T. Dev Biol Stand. 1995;84:137-44. Dev Biol Stand. 1995. PMID: 7796946 Review. No abstract available.